朗進科技(300594.SZ)擬不超500萬元在青島西海岸新區設立全資子公司
格隆匯5月28日丨朗進科技(300594.SZ)公佈,公司於2020年5月28日召開第四屆董事會第十九次會議,審議通過了《關於公司擬投資設立子公司的議案》。根據公司發展戰略規劃,公司擬投資不超過人民幣500萬元,在青島市西海岸新區投資設立全資子公司青島明德慧創檢測技術有限公司(“明德慧創”,公司名稱暫定,以工商登記為準)。
青島明德慧創檢測技術有限公司經營範圍:實驗室和外場檢驗檢測、技術諮詢、技術服務與轉讓、解決方案服務、質量技術諮詢培訓、認證認可。(依法須經批准的項目,經相關部門批准後方可開展經營活動)
公司擬在青島西海岸新區投資設立全資子公司,意在承接公司檢測試驗任務的同時,將公司檢測服務標準化並對外承接業務,對外提供相關技術諮詢和服務,拓展公司業務領域,將公司打造成為高端裝備形象和水平的企業,加快推動公司戰略目標的實現。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.